Oesopheageal motility in schistosomal hepatic fibrosis with and without sclerotherapy

Esophageal motility studies including upper esophageal sphincter pressure and lower esophageal sphincter pressure in SHF were studied in patients with SHF with and without sclerotherapy and control group. There was no significant change in upper esophageal sphincter pressure in all groups. Lower esophageal pressure showed a significant decrease in patients with sclerotherapy as compared to the SHP patients without sclerotherapy and the control group. Esophageal body waves are significantly affected in SHF cases with sclerotherapy

Antithrombin III in relation to other coagulation disorders in cases of diabetic ketoacidosis before and after treatment

This work was done on 20 patients with diabetic ketoacidosis. Coagulation studies were done to every patient before and after treatment including prothrombin time, partial thromboplastin time, antithrombin III, fibrin degradation products. It was found that the partial thromboplastin increased significantly after control of the ketotic state, the antithrombin III decreased significantly after treatment, no change was found in prothrombin time and platelet count